Literature DB >> 1711924

Colicinogeny of O157:H7 enterohemorrhagic Escherichia coli and the shielding of colicin and phage receptors by their O-antigenic side chains.

D E Bradley1, S P Howard, H Lior.   

Abstract

Twenty O157:H7 enterohemorrhagic Escherichia coli strains from patients with different clinical conditions were tested for colicinogeny and the presence of Verotoxin (VT) genes. From bloody diarrhea cases, 7/8 isolates and from hemolytic uremic syndrome cases 3/5 isolates all synthesized what appeared to be colicin D. The remaining strains, which included 7 from asymptomatic sources, were noncolicinogenic. The plasmid determining the colicin was found to be 1.4 kb larger than the 5.2-kb pColD. The colicin D protein had a molecular weight of about 90,000, whereas the O157 colicin was 87,000. The plasmid was designated pColD157 to reflect these differences. Of O157:H7 isolates 17/20 had genes for both of the Verotoxins VT1 and VT2, and the remaining 3/20 for VT1 only. There was no correlation between the presence of VT determinants and colicinogeny or symptoms. The O157:H7 strains exhibited significant resistance to other colicins and bacteriophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711924     DOI: 10.1139/m91-014

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  11 in total

1.  Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Authors:  Matija Rijavec; Maruska Budic; Peter Mrak; Manica Müller-Premru; Zdravko Podlesek; Darja Zgur-Bertok
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

2.  Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes.

Authors:  M M Doolittle; J J Cooney; D E Caldwell
Journal:  J Ind Microbiol       Date:  1996-06

3.  Structure and function of plasmid pColD157 of enterohemorrhagic Escherichia coli O157 and its distribution among strains from patients with diarrhea and hemolytic-uremic syndrome.

Authors:  C Hofinger; H Karch; H Schmidt
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans.

Authors:  H Toshima; M Hachio; Y Ikemoto; J Ogasawara; A Hase; K Takahashi; H Masaki; Y Nishikawa
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria.

Authors:  T Zhao; M P Doyle; B G Harmon; C A Brown; P O Mueller; A H Parks
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria.

Authors:  S Yaron; G L Kolling; L Simon; K R Matthews
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

7.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

8.  Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7.

Authors:  S E Murinda; R F Roberts; R A Wilson
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

9.  Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-.

Authors:  H Karch; H Böhm; H Schmidt; F Gunzer; S Aleksic; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.